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Abstract
Background: The aim of this work was to detect antigens, non-self to the dam, potentially present
in chick embryo prior to organogenesis with a view to establishing the consequences of their
neutralization on chick development. To this end, hens were immunized with the extract from
embryos incubated for 53 h. Their eggs were either used to isolate immunoglobulins for dot and
blot tests or incubated for variable lengths of time.
Results: Immunoblot tests, using adsorbed primary and secondary antibodies against paternal
serum, revealed the presence of at least four antigens of 32, 34, 70 and 200 kDa that can be
classified as soluble alloantigens. The same antibodies against chick embryo extracts (between 53
h and 9)  showed at least five aged antigens of 34, 52, 90, 200 and 250 kDa, not detected in cock
serum, that can thus be considered as soluble, foreign to the immunized hens and transitory
antigens. The abnormalities observed included arrested development and fetal death, as well as
minor functional damage in the few chicks that were born alive. The ratio of abnormal to normal
embryos was 2.85 in the experimental group and 0.43 in the control group. With regard to
congenital anomalies it must be said that of the 81 eggs incubated only four chicks were born alive,
and of these, only one had a healthy birth and subsequent growth. The other three showed a
transitory ataxia and one of them presented adult lumbar scoliosis and asymmetric pelvis.
Conclusions: The problem of recurrent spontaneous abortions is revisited in the light of these
results. Some recent data suggest that soluble alloantigens may be candidates for a new etiological
entity in recurrent spontaneous abortions. They can also be the cause of some congenital
anomalies. The soluble, foreign, transitory antigens may have a similar effect although there is no
supportive data in the literature.
Background
Chick embryo antigens were successfully neutralized with
specific antibodies for the first time in the 1950s. Tests
were then conducted with a view to determining what
happened when a given protein or protein group ceased to
serve its physiological function. Since then, a variety of
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antisera for pure or mixed adult and embryo antigens
have been tested. Anti-embryo antibodies rendered spe-
cific by adsorption with adult antigens and additionally
purified immunoglobulins have also been used for this
purpose. Some studies have been carried out in vitro and
others in ovo. Either the growth of specific tissues or organs
was altered, or complete body development was pre-
vented and death caused in various ways [1–13]. Specific
sera against differentiation antigens in chick embryo (e.g.
α-fetoprotein) have also been used in this context. Some
in ovo experiments involved injection of its heterologous
antiserum from rabbit into the yolk sac. Neutralizing α-
fetoprotein was found to give rise to congenital malforma-
tions, arrested development and fetal death [14]. Also,
incorporating  α-fetoprotein antiserum to the culture
medium was found to disrupt histological development
of the retina [15].
Previous experiments revealed the presence of seven tran-
sitory antigens (TrAg) in allantoic fluid, four of which
were also encountered in chick embryo liver [16], and of
three TrAg in the chorioallantoic membrane of 13-day
chicks [17], in addition to α-fetoprotein in both cases.
This aroused the author's interest in searching for antigens
in the early embryo, which might be present prior to org-
anogenesis. Should any be found, this would allow one to
determine the involvement of these proteins in such a cru-
cial developmental stage. To this end, chick embryos incu-
bated for 53 h – which corresponds to stages 14–15 in
Hamilton and Hamburger's Table [18] – and soluble
embryonic antigens were examined. Because heterolo-
gous antisera were avoided for the reasons stated under
Discussion, the study was conducted by immunizing hens
with embryo extracts. By definition, inoculated hens only
produced antibodies against those proteins with which
their specific immature B cells (sIgM+ IgD- B lym-
phocytes) never came into contact with high avidity dur-
ing their central clonal negative selection and therefore
these specific B cells were not removed [19]. This
approach focuses on the findings of two groups of highly
attractive and yet scarcely studied proteins, namely: (a)
soluble alloantigens (sAlloAg), which are permanent anti-
gens of paternal origin, and (b) soluble, foreign to the
dam and transitory antigens (sF-TrAg). These last fetopro-
teins are coded by genes that are only expressed during the
embryonic period [20] or some weeks after hatch preced-
ing maturity of the embryo's immune system and there-
fore they are non-self to the adult. Both groups fitted the
designation "soluble, fetal, dam-foreign antigens" (sFF-
Ag). It is known that gene conversion and Ig diversifica-
tion are ongoing in the bursa through sexual maturity of
the bird. Since gene conversion randomly creates new spe-
cificities of Ig, new Ag specific clones are being produced
throughout of the first 16 weeks or so after hatch [21]. If
then the specific sIgM+ IgD- B lymphocyte appears for a
given sF-TrAg when already its synthesis has been stopped
or already is not present in the chick after hatch, then this
event will have the same consequences – according to the
position of this article – as for the case of an sF-TrAg that
was only present during the embryonic period.
Hen IgG antibodies are known to pass from blood to yolk,
and so, when the egg is incubated, IgY are transferred from
the yolk sac to the embryo via the bloodstream. Therefore,
if these specific IgY react with their respective antigens,
they will do so in ovo, in a natural physiological medium,
as molecules synthesized by the dam itself. Theoretically,
this reaction can suppress the functions of these proteins,
particularly of enzymes. In broad terms, this consequence
has been experimentally confirmed (e.g.  in [2,5] and
[14]). However, this cannot always be the case for various
reasons, including the inability of the IgY molecule to
access the cell compartment holding the corresponding
protein, its inability to block its active site -if it is an
enzyme- even if it can reach it or that of the amount of
antibody supplied by the yolk sac to neutralize a large
enough amount of antigen produced by the embryo to
disrupt its development. On the other hand, if neutraliza-
tion is efficient enough, some abnormality in embryofetal
development will occur and whether or not such a mor-
phological or functional abnormality is compatible with
life can be determined.
Because of the many questions involved, this work was
addressed as a "preliminary experiment" intended to pro-
vide experimental answers and determine the type and
number of sFF-Ag involved. Only if the immunization
were pathogenic would reporting the results make sense;
were this the case, it would warrant planning additional,
more detailed studies involving the use of purified sam-
ples of the antigens found and immunizing as many hens
series in order to identify the specific developmental alter-
ations caused in each or even to conduct a study on a
mammal with a hemochorial placenta, similar to that in
humans, and its specific sFF-Ag.
In this work, four sAlloAg and five sF-TrAg in 53-h chick
embryo were detected. Some (or all) of them may to cause
various embryonic development alterations including
arrested development and fetal death, as well as congeni-
tal abnormalities in a few cases.
Results
Figure 1 shows the breed and gender of the birds used and
the procedure followed to obtain the antigenic material,
the embryonated eggs from the immunized hens, and the
IgY from the yolk to detect antigens through dot- and
Western immunoblot.BMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
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Dot-blot was used for controlling the purity of the pri-
mary and secondary antibodies and for optimizing these
reagents. Anti-ceE IgY gave positive results against White
Leghorn (W-L) and Plymouth Rock (P-R) hens' sera and
goat serum. Anti-control IgY gave positive results against
cock, W-L and P-R hens' sera. "Normal" IgY gave positive
results against cock serum. The anti-ceE IgY detected 12
"contaminant" antigens in cock serum when was tried
with the immuno-blot test (Figure 2). Dot-blots were
repeated but with successive adsorptions of the primary
and secondary labeled reagents until the corresponding
negative reactions were obtained (results not shown, but
see Figure 3).
With these fully adsorbed reagents, the Western immuno-
blots were carried out (Figures 3 and 4). In this way one
can see that the adsorbed anti-ceE IgY does not detect any
antigen in sera from W-L and P-R hens but at least four
sAlloAg are found in W-L cock serum of circa 200, 70, 34
and 32 kDa (Figure 3). On the other hand, five bands (sF-
TrAg) of circa 250, 200, 90, 52 and 34 kDa are at least pat-
ents among the ceE from different ages (53 h, 72 h, 5 d, 7
d and up at least 9 d) (Figure 4).
Of the 81 embryos studied, 74.1% exhibited some abnor-
mality, which, in many cases, led to death; by contrast,
only 30.3% of the 66 controls developed some abnormal-
ity. The ratio of total to abnormal embryos was 1.35 for
the experimental group and 3.3 for the control group.
That of abnormal embryos to normal embryos was 2.85
for the former group and 0.43 for the latter (Table 1).
There are 147 cases as a whole categorized as we see in the
Table 2. The response between the two groups considered
(immunized and control) is compared. The Fischer' exact
test, unilateral, made for table 2 × 2 shows a limit proba-
bility of p < 0.001. Therefore, it may be considered that
the proportion of abnormal chicken from immunized
hens is significantly higher than the respective proportion
in the control group (Table 3).
Sequence of steps taken in this study Figure 1
Sequence of steps taken in this study.
W W WH H HI I IT T TE E E L L LE E EG G GH H HO O OR R RN N N C C CO O OC C CK K K
               (cock or paternal serum)
       EGGS FOR INCUBATION 
           53-h; 72-h; 5-d; 7-d; 9-d 
53-h CHICK EMBRYO  
EXTRACT  FOR  
IMMUNIZATION 
W W WH H HI I IT T TE E E L L LE E EG G GH H HO O OR R RN N N H H HE E EN N NS S S
(hens or dams of the 
studied embryos) 
        FRESH EGGS 
TO EXTRACT IgY FROM YOLK FOR 
IMMUNOBLOT 
P P PL L LY Y YM M MO O OU U UT T TH H H R R RO O OC C CK K K H H HE E EN N NS S S
CHICK EMBRYO EXTRACT OF 
EACH AGE GROUP FOR 
IMMUNOBLOT 
A A AU U UT T TO O OC C CH H HT T TH H HO O ON N NO O OU U US S S C C CA A AM M MP P PE E ER R RO O O
C C CO O OC C CK K K
TO INCUBATE.  THEY WERE OPEN 
FROM 30-h TO 21-d TO STUDY THE    
DEVELOPMENT OF EACH EMBRYO 
This immunoblot shows 12 bands produced by native anti- ceE IgY against cock serum, and native anti-chicken IgG  conjugate Figure 2
This immunoblot shows 12 bands produced by native anti-
ceE IgY against cock serum, and native anti-chicken IgG con-
jugate. The corresponding antigens were removed through 
adsorption of the primary antibody with hens' sera and the 
secondary antibody with hen's liver in order to visualize the 
sFF-Ag.BMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
Page 4 of 12
(page number not for citation purposes)
Figures 5,6,7,8,9 show selected annotated examples of
arrested development, malformations and fetal death. In
some cases, the abnormality was a mere delay of 24 h or a
little longer, with no other dysmorphology when viewed
under a magnifier. Some of the eggs opened at the theo-
retical time of hatching showed already dead chicks and
exhibited a greater or lesser lack of yolk resorption. One
that looked normally developed to the naked eye was still
breathing at the time but died immediately. Three that
were alive and exhibited some residual yolk were left in
one half-shell and placed in the incubator to complete
their maturation but died within 18 h. Some eggs were
allowed to stand for 6–24 h after 21 days of incubation in
the hope that they would complete their development
and the chicks would start hatching. This was not the case
and the chicks were found dead when the eggs were
opened. A detailed study of the delays and the macro-
scopic and microscopic dysmorphologies observed is cur-
rently under way. Of the four chicks that succeeded, only
one was born healthy and grew with no apparent abnor-
mality. The other three were born with transitory neuro-
logical disorders, ataxia and an inability to peck at food
and drink; one died after 12 days through digestive prob-
lems not associated to the experiment, whereas the others
reached adulthood healthy although one had a bony pro-
tuberance in the joint between the femur and pelvis. The
radiographs and autopsy revealed the presence of lumbar
scoliosis and an asymmetric pelvis that caused the tro-
chanter from the femur to protrude. All these and other
signs and symptoms observed also will be published in
more detail as congenital anomalies.
Discussion
When a serological technique in dot- and Western immu-
noblot is used, the risk exists that the primary and/or the
secondary antibody may be contributing to spurious
background bands. In our case these contaminant anti-
bodies were detected in dot-blot using cock and goat sera
as antigens, and native anti-ceE IgY, anti-control IgY and
"normal" IgY, and as secondary antibody native anti-
chicken IgG conjugate. All this indicated that the false
positive reactions found with the anti-ceE was neither
caused by the embryonic material employed in the immu-
nization (since they occurred also with the anti-control
IgY), nor caused by the Freund adjuvant because the "nor-
mal" IgY also gave a false positive. The false positive reac-
Western immunoblot from SDS-PAGE with gradient 4–15%  acrylamide-bis Figure 3
Western immunoblot from SDS-PAGE with gradient 4–15% 
acrylamide-bis. Paths 1–3: W-L cock serum diluted 1:4, 1:2 
and 1:1, respectively. 4: prestained MW standards high range. 
5: nothing. 6: prestained MW standards low range (the three 
asterisks point out those prestained MW that are weak). 7–
8: W-L hen serum diluted 1:2 and 1:1, respectively. 9–10: P-R 
hen serum diluted 1:2 and 1:1, respectively. The stars point 
out each one of the four bands. The primary antibody was 
anti-ceE IgY adsorbed with sera from W-L hen and P-R hen, 
and the secondary antibody was adsorbed with liver extract 
from W-L hen. Four sAlloAg from W-L cock serum are 
present in the 53-hour-old chick embryo with circa 200, 70, 
34, and 32 kDa. This adsorbed anti-ceE IgY does not detect 
any antigen in sera from W-L and P-R hens (paths 7–10).
Western immunoblot from SDS-PAGE carried out simulta- neously with that of the Figure 3 and with the same primary  and secondary antibodies Figure 4
Western immunoblot from SDS-PAGE carried out simulta-
neously with that of the Figure 3 and with the same primary 
and secondary antibodies. Paths 1 and 10: prestained MW 
standards high and low range, respectively. Paths 2–5: four 
different samples from ceE 53 hours. Paths 5–9: ceE 72 hours 
and 5–7–9 days, respectively. Five sF-TrAg with circa 250, 
200, 90, 52 and 34 kDa are present in 53-hour-old chick 
embryo inasmuch as all sF-TrAg present in the different age 
samples was detected by the antibodies induced by the chick 
embryo 53 h-old extract. The six stars point out the five 
bands.BMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
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tion observed in the goat serum has not been studied, but
was probably caused by a cross-reaction among goat
serum proteins and rabbit antibodies against contami-
nant proteins from avian serum in the preparation of the
anti-chicken IgG (conjugate). Its adsorption with liver
extract from hen was useful since it yielded firstly a volu-
minous pellet and needed after to be adsorbed with
Sepharose-CNBr-liver extract in order to obtain negative
results. An exhaustive adsorption with W-L and P-R hens'
sera for the primary reagents (anti-ceE IgY and anti-con-
trol IgY) was also made up to get negative results. Using
native reagents, various non-sFF-Ag are detected in cock
serum through primary antibody anti-ceE IgY (Figure 2).
The nature and the significance of these "contaminant"
antibodies lies beyond the goal of the current study, where
only fetoproteins not present in dam's serum are studied.
However, if some of them are autoantibodies (as they
probably are), it will be necessary to make them a subject
of further study in the future in view of their importance
in medicine.
The classification made, that some fetoproteins found are
sAlloAg and other sF-TrAg is based on the argument that
they are found in cock serum and in ceE respectively, irre-
spective that in the two immunoblot tests there are two
bands with the same relative mobility (34 and 200 kDa),
given the lesser amount of serum proteins (and of sAl-
loAg) in ceE than in cock serum. Both immunoblot tests
were developed with the same primary and secondary
antibody, both were developed in the same running and
each band of each membrane measured in regard to its
own high and low standard MW markers. However,
Table 1: Normal and abnormal embryonated eggs from immunized and control hens
Source Total N (%) Normal Abnormal N (%) Ratio
N (%) ?a Living Dead Total T/Anb An/Nc
Immunized hens 81 (100) 21 (25.9) 27 (33.3) 11 (13.2) 22 (27.1) 60 (74.1) 1.35 2.85
Control hens 66 (100) 46 (69.7) 5 (7.5) 2 (3.0) 13 (19.7) 20 (30.3) 3.3 0.43
a ?, abnormal but uncertain as to whether the embryo was dead or alive. b Total/Abnormal c Abnormal/Normal
Table 2: State – Response cross-tabulation
Count
Response Total
Normal Abnormal
State
- Immunized 21 60 81
- Control 46 20 66
Total 67 80 147
Table 3: Chi-Square tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Point Probability
Pearse Chi-Square 28.090 1 0.000 0.000 0.000
Continuity Correction 26.353 1 0.000
Likelihood Ratio 28.955 1 0.000 0.000 0.000
Fischer's Exact Test 0.000 0.000
Linear-by-Linear Association 27.899 1 0.000 0.000 0.000 0.000
No. of Valid Cases 147BMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
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because the ceE contains paternal serum proteins (sAl-
loAg) only when one gets a potent anti-ceE IgY and a con-
centrate ceE or better a purified sFF-Ag sample from ceE,
can one definitively confirm these results. In fact, one
sample of that primary antibody would be adsorbed only
with hen serum and another sample would be doubly
Presumptive teratological consequences of the soluble, fetal  and dam-foreign antigens (sFF-Ag) being neutralized by their  specific IgY Figure 5
Presumptive teratological consequences of the soluble, fetal 
and dam-foreign antigens (sFF-Ag) being neutralized by their 
specific IgY. Both embryos were 53-h old. The one on the 
left (the control) exhibited normal development: with 
twenty-two pairs of somites, optic cup, lens and choroids fis-
sure, 1st, and 2nd pharyngeal pouch and the arches 1 and 2, 
otic vesicle, normal looping of the heart (atrium, ventricle 
and troncus arteriosus), etc. On the right, the embryo shows a 
more reduced body size, and all the abovementioned ana-
tomical structures are much less noticeable here. What is 
most noticeable is the malformed development of the brain, 
pharynx and heart.
The three embryos were 53-h old Figure 6
The three embryos were 53-h old. The one on the left was 
the control. Those in the middle and on the right exhibited 
noticeably arrested development.
The three embryos were 53-h old (the control is not shown) Figure 7
The three embryos were 53-h old (the control is not 
shown). The one on the right exhibited 8 pairs of somites 
and delayed development of heart and head, another in the 
middle had a head corresponding to stage 11 in the Table of 
Hamburger-Hamilton but the rest of the body was even 
more delayed and that on the left had a square cephalic end 
as its most salient morphologic abnormality.
Two 3.5 days-old chick embryos showing few differences in  their external aspect Figure 8
Two 3.5 days-old chick embryos showing few differences in 
their external aspect. The embryo control is on the right. On 
the left the embryo shows mainly a minor delay in its 
development.BMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
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adsorbed with hen and cock sera. Then the results
obtained in each membrane will be able to be compared.
Using thus this doubly adsorbed primary antibody against
ceE, the bands can only be sF-TrAg. When the primary
antibody only adsorbed with hen serum reacts against
cock serum the present bands can only concern to sAl-
loAg. In accordance with this reasoning the antigens of 34
and 200 kDa present in both cock serum and ceE (Figure
3 and 4) should be considered, in my personal opinion,
provisionally in a case as sAlloAg and in other as sF-TrAg.
The chick embryo extract used contained some proteins
the synthesis of which is dictated either by paternal genes
(soluble alloantigens) or by embryonic genes [20] that
ceased to be expressed before the immune system had
matured (soluble foreign transitory antigens) before or
after hatch. So both protein classes are foreign antigens to
the hens, if they come into contact with their immune sys-
tem during the experiment, or -one may speculate- in a
natural manner in human and some rodent species if they
cross the placenta. This common feature allowed them to
be used to immunize hens, and the antibodies thus
induced to expose their presumptive teratogenic and/or
abortogenic action in a completely physiological manner.
Finally, the antigenic analysis conducted via immunoblot
tests identified the proteins most likely to be the origin of
the pathological effects observed from minimal
information about the sAlloAg (viz. their molecular
weight and soluble nature in cock serum). From these
data it follows that the sAlloAg were detected because the
chick embryo was included in the area vasculosa up to the
sinus terminalis with the incipient serum proteins (ceE)
that were therefore involved in the immunization process.
Because serum proteins can migrate into the allantoic cav-
ity, some of the TrAg detected in allantoic fluid from chick
embryos might also be sAlloAg [16]. This antigenic analy-
sis also allowed the detection of sF-TrAg, not present in
cock serum, the synthesis of which stops before its specific
immature lymphocyte appears and they are already not
present -which is obvious as it induces the production of
antibodies by the hens- before or after hatch. The fact that
some sF-TrAg were not detected in all embryos' extracts
(paths 2–9, Figure 4) does not necessarily mean that it
ceases to be synthesized at that age as its detection may be
hindered by a diluting effect arising from the growth in
body volume with age, by small variations in the
preparation procedure of each sample and even by the
individual "history" of each Eppendorf tube. For all these
reasons, they must be purified, used at higher
concentrations, raised higher concentration of antibody
in order to obtain information other than its molecular
weight, soluble nature and the fact that they are foreign to
the dam.
IgY against some or all sFF-Ag were found to induce pre-
sumptively a number of dysmorphisms and/or functional
alterations incompatible with life; also, all but one of the
few chicks that were born alive had a congenital transitory
neurological disease. In a separate study, we shall examine
in detail the relationship between the date at which devel-
opment was arrested and the date at which morphological
abnormalities on the macroscopic and microscopic level
appeared in relation to the duration of immunization at
the time the corresponding egg was laid, as well as any
similarities between abnormalities in the batch of eggs
that were laid only a few days apart but were incubated
simultaneously. There was a significant difference
between the total number of embryos from immunized
and control hens and that of abnormal embryos in the
two groups. This was also the case with the ratios of
abnormal to normal embryos in each group (Table 1).
Two previous studies were approached in a similar way to
the present one. One examined pre-differentiation stages
in the chick embryo. To this end, hamsters were immu-
nized with homogenates from 24-h, 72-h and 6-d chick
embryos. The greatest number of abnormalities and
deaths was caused by the antiserum induced with the
homogenate from 72-h embryos, followed by those from
24-h and 6-day embryos [2]. The other study was aimed at
determining whether the early chick embryo is antigeni-
cally different from that of the adult and at examining the
effect of its anti-embryo antibodies on the development of
the homologous embryo. To this end, rabbits were
injected an extract from embryos incubated for 72 h and
the antiserum inoculated to embryonated eggs incubated
for 72 h. Abnormalities were observed within 12 h and
deaths within 5 min to 8 h after inoculation [5]. In judg-
A 21 day-old chick embryo found dead 9 hours after the pre- dicted hour of hatching without external anomalies Figure 9
A 21 day-old chick embryo found dead 9 hours after the pre-
dicted hour of hatching without external anomalies.BMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
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ing the results of these pioneering experiments, one
should take into account that both the hamsters and the
rabbits immunized with material from chick embryo pro-
duced antibodies against the wide variety of antigens con-
tained in it – permanent antigens included. All these
antibody species were subsequently inoculated into the
embryonated egg, which was assumed to be able to neu-
tralize the corresponding antigen classes. The only anti-
permanent antigens antibodies detected in our experi-
ment were anti-sAlloAg. Hence our respective results can-
not be compared.
Regarding our immunization procedure, we should note
the disadvantages of using heterologous sera if the
antigens involved are foreign to the hen used to examine
the action of the corresponding antibodies in their embry-
onated eggs. Fresh normal serum from some animals is
toxic to the chick embryo. In fact, rabbit serum has been
found to contain a thermolabile substance that is embryo-
toxic; this requires heating the anti-embryo serum before
inoculation, which reduces its ability to induce unspecific
abnormalities in relation to unheated serum [5]. In addi-
tion to rabbit sera, dog, pig and frog sera are also highly
embryo-toxic. On the other hand, guinea pig, duck and
mouse sera proved inactive, and cow, rat and goat sera
exhibited a teratogenic activity level between the two
extremes [22]. Human serum is also very embryo-toxic
[23]. When a heterologous anti-chick embryo serum must
be made specific against one (e.g. α-fetoprotein [14]) or
several transitory antigens by removing anti-permanent
antigen antibodies by adsorption with adult serum, with
a view to examining the effects of neutralizing their
respective antigens in ovo, one has the disadvantage that
the embryonated egg is inoculated not only with the pro-
teins in the heterologous antiserum, but also with those in
the hen or cock serum used for adsorption. This can be
avoided by purifying immunoglobulins, which include
specific antibodies, by precipitation with ammonium
sulphate [9,12,13] or by other methods; this is labor
intensive and causes the loss of specific IgG. Finally, the
embryonated egg must be manipulated in all cases.
What remains of this discussion is devoted to establishing
apparent or hypothetical relationships between these
results and the problem of recurrent spontaneous abor-
tion (RSA) in humans. If some sAlloAg or an sF-TrAg
reaches the mother, it will induce the production of
antibodies that may come into contact with the fetus and
cause a congenital disease or abortion.
There have been many attempts at identifying the causes
of RSA without success. A high proportion of RSA of
unknown origin has been ascribed to alloimmune factors;
however, because of the lack of clinical or laboratory tests
to confirm classical alloimmune RSA diagnoses, they are
considered "exclusion" or "unexplained" diagnoses [24].
Moreover, the therapeutic counter-test involving immuni-
zation with paternal white cells or immunoglobulins, or
of one third-party, in order to induce the production of
blocking antibodies against the paternal membrane
alloantigens in the mother, has failed to meet the initial
expectations [24–26]. The embryofetal pathology of clas-
sical alloantigens associated to the cell membrane has
been known for long and appears to have been virtually
exhausted as its concepts and techniques cannot account
for so many cases of RSA.
Some recent data suggest that sAlloAg may be candidates
for a new etiological entity in embryofetal immunopa-
thology. In most of the following references, soluble MHC
antigens (sMHC) detected in maternal plasma were
assumed to originate from the mother. In some cases
where their presence coincided with RSA, one may still
suspect a fetal origin- and this may be the case with the
results of this work. If, on the other hand, the assumption
that fetal sHLA never cross the placental barrier [27]
holds, then extrapolating our results to humans would be
unwarranted. Virtually all class I MHC antigens can be sol-
ubilized and be present in organic fluids [28]. One metal-
loprotease is able to solubilize its heavy chain (HC)
[29,30]; this HLA-HC, and the whole HLA molecule
(HLA/2m), has been detected in healthy individuals and
during graft rejection [31]. Recently, truncated soluble
class I RT1.Aa MHC antigens were found to induce alloim-
munity [32]. Women with RSA have been found to have
increased class I sHLA levels the origin of which has been
related to that of the increased levels encountered in
patients with acute rejection of transplanted organs [33].
HLA antigens of fetal origin are known to be present in the
maternal circulation throughout pregnancy beginning at
8 weeks. As early as the 8th week, a woman can have
alloantibodies that form complexes with soluble HLA
alloantigens. In some women, the production of anti-anti-
HLA antibodies is apparent already in the first trimester;
in others, it takes somewhat longer. Antibody specificity
analyses have revealed that some healthy primiparous
women develop antibodies reactive with self-HLA anti-
gens. Although allo- and autoantibodies responses appear
to be modulated by soluble HLA antigens, cyclic changes
in alloantibodies levels and the selective response of the
mother to some, but not all, paternal HLA antigens are
more consistent with the production of anti-idiotypic
antibodies [34]. Therefore, one can assume that pregnant
women respond to their fetal alloantigens with alloanti-
bodies, and that these are suppressed by soluble HLA and
by their anti-idiotypic antibodies. If this is so, many cases
of RSA may have involved some failure in this defense
mechanism, and non-neutralized maternal antibodies
may have crossed the placenta and suppressed the biolog-
ical function of paternal alloantigens in the fetus, therebyBMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
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leading to death (abortion) or to the development of con-
genital diseases. Why then were anti-sFF-Ag IgG in the
immunized hens not blocked by their anti-idiotypic anti-
bodies? Perhaps, under natural conditions, birds undergo
no antibody induction by sFF-Ag from their offspring.
γ-Interferon facilitates the release of soluble class II MHC
antigens present in the cytoplasm of trophoblastic cells.
Thus, a purified protein of 70 kDa was found to increase
the abortion rate in mice upon inoculation [35]. Moreo-
ver, the DQA1*0201/DQB1*0201 haplotype is more fre-
quently encountered in husbands of women with RSA
than in control couples. Thus, in a group of seven hus-
bands of women with RSA who were heterozygotic for
this haplotype and shared no DQA1*0201 allele with
their wives, the haplotype was transferred to 6 of the 7
aborted fetuses. Although the number of cases was fairly
small, one cannot exclude HLA-DQ antigens as inducers
of these abortions [36].
Based on the above and on the results of this work, it
would be interesting to systematically ascertain the mater-
nal or fetal origin of the sAlloAg found, at more or less
increased levels, in serum from mothers with RSA and to
determine whether they belong not only to classical class
I or class II, but also to class III. Surprisingly, there is little
reported association of class III sMHC antigens to RSA. A
decade ago two articles were published which
demonstrated a statistically significant increase of serum
complement C4 [37] and of complement C4 "null" alleles
[38,39] in women with RSA. Based on the large number of
proteins that are coded by class III MHC – most of which,
in addition, are polymorphic – [40], some proteins might
correspond to some sAlloAg found in chick embryos (e.g.
C4 factor of complement is a β1E-globulin with 209 kDa,
near the sAlloAg 200 kDa (see Table 4, which shows the
data for the four avian sAlloAg with a MW identical with
or close to previously reported ones, irrespective of any
other criteria).
The lack of reported instances of soluble transitory anti-
gens foreign to their dam (sF-TrAg) provides no basis for
discussing the presumptive involvement of these fetopro-
teins in the embryofetal pathologies described here,
which probably occur in humans as well.
Finally, the presence of these interesting fetoproteins, sFF-
Ag, in the early chick embryo gives us reason to think that
some of them may play an important physiological role in
the organogenesis.
Conclusions
The chick embryo is an extremely convenient animal
model for identifying the underlying immune mecha-
nisms of the abortions and malformations caused by anti-
sFF-Ag antibodies as the physiological separation between
an embryo and its dam is anything but small; also, stop-
ping embryonic development and obtaining large
amounts of antibodies from the egg yolk is very easy.
However, the results obtained for the avian model cannot
be extrapolated as such, without further analysis, to
rodents or humans. Experiments involving a mammal
with a hemochorial placenta and the use of purified sAl-
loAg and sF-TrAg, from that specific animal are required to
identify those antibodies with presumptive teratogenic
and/or abortogenic action before the results of this work
Table 4: Molecular weights (kDa) of the class I and II soluble MHC antigen species detected in rodents and humans. Comparison with 
four molecular species of similar MW detected in paternal serum using the immunoblot test with anti-chick embryo antibodies, 
adsorbed with hen serum.
sHLA/2-m class I beta 2-m sHLA-HC class Ia sHLA-HC class Ib sHLA-HC class Ic sHLA class II Reference and animal speciesd
11 44 33 47 H
43 39 48 H
44 40 37–35 49 H
200 50 H
44 39–36 34 51 H
12 39 33 52 H
36 30 H
39 non-RT1.A
associated with β-2 m
36 RT1.Aa 53 R
43 39 35 54 H
70 35 M
200 34 32 70 TWe A
aThe heaviest species resulted from cell shedding and included a transmembrane segment and cytoplasmic tail bThe intermediate species resulted 
from alternate splicing transcript and contained no transmembrane piece cThe lightest species contained neither a transmembrane piece nor a cyto-
plasmic tail dH = human, R = rat, M = mouse, A = avian, TW = this work eThe author does not prejudge here which MHC class or group the sAl-
loAg detected in this work belong toBMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
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can be extrapolated to women. Also, analyses of women
with RSA or malformed children, once a non-immune or
a classical membrane alloantigen-related etiology has
been rejected, should be conducted in search for anti-sFF-
Ag antibodies in maternal serum, whether by use of sero-
logical techniques or by inoculation into pregnant mice
[40]. The information thus obtained will be of assistance
in determining, to some extent, the cause and, with greater
detail, some of the effects of disrupting the maternal
homeostasis that protects the fetus. This in turn will pro-
vide solid support for future preventive or therapeutic
treatments intended to reduce the currently high propor-
tion of spontaneous abortions and congenital diseases of
unknown origin.
Methods
Fertilized eggs
The eggs, from Plymouth Rock hens fertilized by White
Leghorn cocks, were obtained from a commercial farm
and incubated at 38°C and 60% relative humidity in a
laboratory incubator for 53 h in order to prepare antigen
extracts.
Antigen extracts
Each 53-h embryo (viz. at stage 14–15 in the classification
of Hamilton and Hamburger [18]) was withdrawn by
cutting the membrane along the edge of the sinus
terminalis, washed with cold PBS, drained and placed in an
Eppendorf tube containing 0.5 ml of lysis buffer (150 mM
NaCl, 1.0% Triton X-100, 0.5% sodium deoxycholate,
0.1% SDS and 50 mM Tris, pH 8.0) that was immersed in
an ice bath. Overall 20–24 embryos from each batch,
which produced a volume close to 1 ml, were used. Such
a volume was supplied with a protective cocktail of the
following composition: 0.1 mM pepstatin A, 3 mM dithi-
othreitol, 2.5 mM iodoacetamide, 1 mM PMFS, 5 mM
phenanthroline, 3 mM EDTA and 0.01% merthiolate.
After 2 h at 4°C, the homogenate was aspirated and
expelled using an insulin syringe equipped with a thin
(16/5) needle. The non-viscous sample was filtered
through glass wool in another Eppendorf tube and centri-
fuged at 14 000 g for 10 min in an Eppendorf centrifuge
located in a chamber at 4°C. The resulting supernatant
constituted the chick embryo extract (ceE) and was used
to immunize hens and analyze for sFF-Ag by dot-immu-
noblot, SDS-PAGE and Western immunoblot test. The
same or a similar suitable procedure was used to obtain
ceE from embryos incubated for 72 h and 5, 7 or 9 days.
Liver extract from W-L hen was prepared also by this
procedure.
The concentration of proteins in each sample (Figure 4)
and other features were: Path 2: dialyzed ceE 53 h with
stacking buffer (Tris-ClH pH 6.8, 0.5 M), protein concen-
tration 94.4 mg/ml; Path 3: ceE 53 h made only with the
embryos without membrane, 89.2 mg/ml; Path 4: ceE 53
h without special treatment, protein concentration 56.3
mg/ml; Path 5: ceE 53 h without special treatment, 91,7
mg/ml; Path 6–9: ceE 72 h, ceE 5 d, ceE 7 d and ceE 9 d
were each mixed with sample buffer 1:1 when they were
obtained, protein concentration 86.8, 41.6, 46,3 and 39.4
respectively.
Immunized and control hens
Each ceE batch obtained (from 20–24 embryos) was used
to prepare one immunizing dose that was emulsified with
a double volume of Freund adjuvant (complete in the first
injection and incomplete in the rest). Two White Leghorn
(W-L) hens were given an injection of one dose each intra-
muscularly in two aliquots (one on each side of the keel).
Injections were given in three different series with the fol-
lowing sequences: (A) days 1, 15, 29, 38, 59, 66 and 70
(followed by 75-day rest); (B) days 1, 40, 49, 66, 94, 147,
178 and 196 (followed by 60-day rest); and (C) days 1,
21, 36 and 47. Simultaneously, two control W-L hens
were given injections where the ceE was replaced with
PBS.
Embryos from immunized and control hens
An autochthonous Campero cock fertilized the immu-
nized and control hens. Their eggs were incubated in the
laboratory for different lengths of time, from 30 h to
hatching, depending on their intended use. Embryos were
stored in formaldehyde buffered at pH 7.3 for subsequent
histological analysis. A few of them were photographed as
soon as they were obtained.
Obtainment of IgY
IgY was extracted from the yolk [41] of some eggs at
immunization stages B and C with ceE 53 h (anti-ceE IgY)
and from the control hens' yolk (anti-control IgY). For a
punctual objective were also obtained IgY from yolk of
untreated Plymouth Rock hens ("normal" IgY).
Obtainment of sera
Sera from W-L cock, W-L control hen, untreated P-R hen
and goat (the latter from an abattoir) were obtained after
standard procedure and inactivated at 56°C for 30 min
and 0.01% Merthiolate was added.
Dot-blot
Dot-blot for antibody capture assay was carried out onto
nitrocellulose membrane (0.45 µm, Bio-Rad). Antigens
(ceE, cock and goat sera), primary (anti-ceE IgY, anti-con-
trol IgY, and "normal" IgY) and secondary anti-chicken
IgG (developed in rabbits, labeled with horseradish per-
oxidase, Sigma, lot 86H4824) reagents were used in 0.5 µl
volume. The substrate used was diaminobenzidine (DAB,
3,3',4,4'-tetraaminobiphenyl) with NiCl2as an enhancer
[43].BMC Immunology 2003, 4 http://www.biomedcentral.com/1471-2172/4/6
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Adsorption of spurious antibodies
The primary reagents, anti-ceE IgY and anti-control IgY,
were used native and adsorbed with a tenth part of hens'
sera (of which half was from W-L hen and half from P-R).
The labeled secondary reagent was used native and
adsorbed with a tenth part of liver extract from a W-L hen.
The three antibody reagents with their quoted antigens
were incubated for 2 hours at room temperature in an
end-over-end mixer and spun, each one showing a con-
spicuous pellet. However, these anti-ceE IgY and anti-con-
trol IgY, together with the anti-chicken IgG conjugate so
adsorbed, still gave false positive results in dot-blot
against the antigens W-L cock, W-L hen, P-R hen sera and
goat serum. Obviously always there was a positive reac-
tion between cock serum and anti-ceE IgY. This served as
a positive control and for optimizing the dilutions of the
reagents. Then anti-ceE IgY and anti-control IgY were
mixed with Sepharose CNBr coupled to hens' sera (half
from W-L hen and the other half from P-R one) and the
anti-chicken IgG conjugate was mixed with Sepharose
CNBr coupled to liver extract from W-L hen [44] After 18
hours of incubation to +4°C in an end-over-end mixer, all
of them were spun and the supernatants used later. After
other controls, it was checked that with this treatment all
the spurious antibodies had been removed and the false
positive results were thus avoided. Then these reagents
could be used in Western immuno-blots. When they are
used no adsorbed they will name "native".
SDS-PAGE and immunoblot tests
The protein components of the ceE and cock serum (and
W-L and P-R hens sera, as control) were separated using
the SDS-PAGE technique without reducing agents
[43,45]. The SDS-PAGE technique was applied by using
5–10% (Figure 2) and 4–15% (Figure 3 and 4) gradient of
acrylamide-bis. Western immuno-blot was carried out
with the same membrane type and reagents as in dot-blot,
unless otherwise indicated. The membrane transfer
technique was used to detect sFF-Ag with anti-ceE IgY and
anti-chicken IgG conjugate to the dilutions previously
already optimized. Mini-Protean cell III and the pertinent
transfer complements (Bio-Rad) were used for this pur-
pose following the manufacturer's recommendations.
However, the transfer buffer for proteins between 20,000
and 400,000 Da used was as follows: Tris 50 mM, Glycine
380 mM, SDS 0,1% (wt/vol), methanol 20%, distilled
water up to 1000 ml [43]. Prestained standards molecular
weight markers (Bio-Rad), low (control 94504; 113, 92,
52.9, 35.4, 29 and 21.5 kDa, respectively) and high (con-
trol 95686; 207, 117, 95 and 49 kDa, respectively) range
were employed.
Statistical analysis
A comparison of proportions has been made in a table 2
× 2 with a SPSS package, version 11 [44].
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